Roles of E3 ubiquitin ligases in cell adhesion and migration by Huang, Cai
 review
Cell Adhesion & Migration 4:1, 10-18; January/February/March 2010; © 2010 Landes Bioscience
10 Cell Adhesion & Migration volume 4 issue 1
review
Ubiquitin is an evolutionarily conserved protein that consists of 
76 amino acid residues and ubiquitination is a post-translational 
modification process that covalently conjugates single or multiple 
ubiquitins to target proteins.1-3 Most ubiquitination processes can 
be divided into three categories based on the length and linkage 
of ubiquitin chains: K48-linked and K63-linked poly-ubiquit-
ination and mono-ubiquitination.4,5 K48-linked poly-ubiquit-
ination, where ubiquitin is conjugated to another ubiquitin on 
its lysine 48 residue, is degraded by the 26S proteasome.4,6 K63-
linked poly-ubiquitination fulfills a variety of signaling functions 
including protein kinase activation and DNA repair.5 Mono-
ubiquitination usually marks membrane proteins for endocytosis 
and subsequent degradation in lysosomes.5
Protein ubiquitination consists of three sequential steps: acti-
vation of ubiquitin by a ubiquitin-activating enzyme (E1), trans-
fer of ubiquitin from E1 to a ubiquitin-conjugating enzyme (E2), 
and conjugation of ubiquitin to target proteins by a ubiquitin 
ligase (E3).1,2 E3 ubiquitin ligases contain motifs for substrate 
recognition, are primarily responsible for recognizing specific 
substrate proteins, and are the key control points for protein 
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ubiquitination.7-9 So far, approximately 500 E3 ubiquitin ligase 
genes have been identified in humans. The majority of these ubiq-
uitin ligases can be divided into two categories based on specific 
structural motifs: (1) those possessing the HECT (homologous 
to the E6-AP carboxyl terminus) domain; (2) those containing 
the RING (really interesting new gene)-finger domain.10,11
The roles of E3 ubiquitin ligases in regulating cell prolifera-
tion, apoptosis, cancer invasion and neurodegenerative diseases 
have been extensively investigated and reviewed.12-16 However, 
their roles in cell adhesion and migration, processes that play 
pivotal roles in wound healing, embryonic development, cancer 
invasion and inflammation, are only beginning to be recognized. 
Indeed, more and more evidence indicates that E3 ubiquitin 
ligases participate in the regulation of cell adhesion and migra-
tion. Here, I summarize the roles of E3 ubiquitin ligases in cell 
matrix-adhesion and migration, emphasizing their mechanisms 
of action and highlighting future directions.
Cbl
The Cbl (Casitas B-lineage Lymphoma) family of ubiquitin ligases 
in mammals contains three members: c-Cbl, Cbl-b, and Cbl-c, 
encoded by three homologous genes (Fig. 1).17-19 C-Cbl encodes a 
120 kDa cytoplasmic protein, featuring a tyrosine kinase binding 
(TKB) domain in the amino terminal portion, a C3HC4 Zinc-
binding RING finger domain, a proline-rich region and a leucine 
zipper domain in the carboxyl terminal portion.20,21 The C3HC4 
Zinc-binding RING finger domain mediates the E3 ubiquitin 
ligase activity, while all other domains function as protein-bind-
ing modules. Cbl-b and c-Cbl have similar domain structures, 
but their sequences between the proline-rich regions and leucine 
zipper domains show no significant homology.18 Cbl-c retains 
the TKB domain, the C3HC4 RING finger domain and very 
short proline-rich region, but lacks the other carboxyl terminal 
portion.19
Both c-Cbl and Cbl-b are ubiquitously expressed in mamma-
lian cells. They localize in the cytoplasm and are recruited to 
the plasma membrane under certain circumstances.22 Cbl-b also 
associates with the lipid raft.23 C-Cbl is present in the thymus, 
spleen, testis, lung, heart and brain, as well as T- and B-cells, but 
is highly expressed in the thymus and testis.17 Cbl-b is ubiqui-
tously expressed in diversified tissues, including the spleen, tes-
tis, ovary, placenta, heart, thymus, prostate, kidney, brain, lung, 
liver, skeletal muscle and pancreas, but the spleen has the highest 
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recent studies have demonstrated that a number of e3 
ubiquitin ligases, including Cbl, Smurf1, Smurf2, HDM2, BCA2, 
SCFβ-TrCP and XrNF185, play important roles in cell adhesion and 
migration. Cbl negatively regulates cell adhesion via α integrin 
and rap1 and inhibits actin polymerization by ubiquitinating 
mDab1 and wAve2. Smurf1 regulates cell migration through 
ubiquitination of rhoA, talin head domain and hPeM2, while 
Smurf2 ubiquitinates Smurf1, TGFβ type i receptor and raplB 
to modulate cell migration and adhesion. HDM2 negatively 
regulates cell migration by targeting NFAT (a transcription 
factor) for ubiquitination and degradation, while SCFβ-TrCP 
ubiquitinates Snail (a transcriptional repressor of e-cadherin) to 
inhibit cell migration. TriM32 promotes cell migration through 
ubiquitination of Abl interactor 2 (Abi2), a tumor suppressor. 
rNF5 and XrNF185 modulate cell migration by ubiquitinating 
paxillin. Thus, these e3 ubiquitin ligases regulate cell adhesion 
and (or) migration through ubiquitination of their specific 
substrates.
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C-Cbl interacts with a great number of proteins. This topic 
was extensively reviewed recently.45,46 Briefly, c-Cbl interacts with 
c-Met, EGFR, PDGFR, Src and Syk through its TKB domain, 
and binds CrkL, Fyn, Grb2, Lyn, PI 3-kinase, PLCγ, Src and Syk 
via its proline-rich region (Fig. 1). The phosphotyrosine residues 
at the C-terminal portion are associated with Abl, CrkII, CrkL, 
Fyn, PI 3-kinase, Src and vav, whereas the RING finger domain 
recruits E2 ubiquitin-conjugating enzymes, such as, Ubc4 and 
UbcH5. In addition, many proteins including c-Kit, FGFR, inte-
grin, paxillin, PKCα/θ, SHIP2 and talin has been shown to asso-
ciate with c-Cbl, but the nature of the interaction remains to be 
determined.
Similar to c-Cbl, Cbl-b also interacts with many proteins, 
including c-Kit, c-Met, CrkL, EGFR, Grb2, PI 3-kinase, PKCθ, 
PLCγ, Syk and vav (Fig. 1).43,47-53 Since the domain structures 
between c-Cbl and Cbl-b are so similar, it is speculated that Cbl-b 
may bind many other binding partners of c-Cbl as well. On the 
other hand, Cbl-b shows different binding capacities toward some 
binding partners than c-Cbl. For example, Cbl-b but not c-Cbl 
binds ubiquitin;54 Also, c-Cbl, but not Cbl-b, forms a complex 
with PI 3-kinase in BCR-Abl-transformed cells.53
Cbl can function as a signaling adaptor by forming complexes 
via its various domains. In fact, many signaling processes regu-
lated by Cbl are mediated through its signaling adaptor function. 
For example, the Tyr731 of c-Cbl provides a docking site for the 
level of expression.18 Cbl-c is expressed primarily in the epithelial 
cells of the small intestine, colon, prostate, adrenal gland, and 
salivary gland, but not in many tissues that express c-Cbl and 
Cbl-b, such as the spleen and thymus.19
C-Cbl undergoes tyrosine phosphorylation upon growth 
factor and cytokine stimulation as well as T-cell receptor (TCR) 
ligation.24-33 C-Cbl is a substrate for several protein tyrosine 
kinases, including Src, Syk, Yes, Fyn and Abl.34-41 In vitro, Fyn 
predominantly phosphorylates Tyr731 and Abl phosphorylates 
Tyr700, whereas Syk phosphorylates Tyr700, Tyr731 and Tyr774. In 
v-Abl-transformed cells, c-Cbl is phosphorylated at Tyr700 and 
Tyr774. Overexpression of various Src family protein tyrosine 
kinases (PTKs) phosphorylates Tyr700, Tyr731 and Tyr774 with-
out apparent specificity.37 In T cells, c-Cbl is phosphorylated 
at Tyr700, Tyr731 and Tyr774 upon TCR ligation.37 In adipocytes, 
c-Cbl is phosphorylated at Tyr371, Tyr700 and Tyr774 in response 
to insulin stimulation.42 Thus, Tyr371, Tyr700, Tyr731 and Tyr774 
are the major tyrosine phosphorylation sites identified in c-Cbl 
(Fig. 1).
Like c-Cbl, Cbl-b also becomes tyrosine phosphorylated in 
response to insulin stimulation and TCR engagement.22,43 In 
adipocytes and Jurkat cells, Cbl-b is phosphorylated at Tyr655 
and Tyr709 upon TCR stimulation (Fig. 1). However, the phos-
phorylation of Cbl-b is much weaker as compared to that of 
c-Cbl upon insulin stimulation and TCR engagement.22,44
Figure 1. Domain structures of the Cbl family members in mammals. Both c-Cbl and Cbl-b have a tyrosine kinase binding (TKB) domain, a C3HC4  
Zinc-binding riNG finger (rF) domain, a proline-rich region and a leucine zipper (LZ) domain. A ubiquitin-associated (UBA) domain overlaps with the 
LZ domain. Cbl-c has a TKB domain, a C3HC4 rF domain and a very short proline-rich region. C-Cbl has four major tyrosine phosphorylation sites: 
Tyr371, Tyr700, Tyr731 and Tyr774, whereas Cbl-b is phosphorylated at Tyr655 and Tyr709. Currently identified major binding partners for each domain  
(or region) are also listed.
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deficiency also promotes cell adhesion and cell surface binding 
to ICAM-1 and enhanced clustering of LFA-1 in Cbl-b(-/-) T 
cells in response to TCR stimulation.59 However, the underly-
ing molecular mechanisms remain to be elucidated.
Cbl and FAK. Cbl ubiquitinates FAK in a STAP-2-dependent 
manner and inhibits T cell adhesion to fibronectin. STAP-2 
(signal-transducing adaptor protein-2) is a signaling adaptor pro-
tein that interacts with FAK and Cbl. Sekine et al.63 showed that 
STAP-2 recruits FAK and Cbl together and mediates the ubiquit-
ination of FAK by Cbl, thus inhibiting cell adhesion to fibronec-
tin. Overexpression of STAP-2 causes a dramatic decrease in the 
levels of FAK, whereas STAP-2 (-/-) T cells have increased FAK 
levels. Furthermore, STAP-2 (-/-) splenocytes or T cells exhibit 
enhanced cell adhesion to fibronectin after PMA treatment, 
whereas overexpression of STAP-2 inhibits integrin-mediated T 
cell adhesion to fibronectin.63
Cbl regulates actin polymerization. Cbl and mDab1. Cbl 
ubiquitinates phosphorylated mDab1 (mouse Disabled homo-
logue 1), thus inhibiting mDab1-induced actin polymerization 
and filopodium formation. mDab1 binds and activates N-WASP 
(neuronal Wiskott–Aldrich syndrome protein) directly, induc-
ing actin polymerization through the Arp2/3 (actin-related 
protein 2/3) complex and filapodium formation. Suetsugu 
et al.64 reported that mDab1 is ubiquitinated in a Cbl-dependent 
manner after it is phosphorylated by Fyn; Fyn activation inhib-
its mDab1-induced filopodium formation. These results suggest 
that Cbl and Fyn negatively regulate mDab1-N-WASP-mediated 
actin polymerization. This pathway may regulate actin dynamics 
during cell migration.
Cbl and WAVE2. Cbl ubiquitinates WAVE2 to inhibit actin 
polymerization and lamellipodium formation. WAVE2, a mem-
ber of the WASP and WAVE family proteins, has a WAVE 
homology/Scar homology domain (WHD/SHD), a basic region, 
a proline-rich region and a VCA region.65 Upon Rac activation, 
WAVE2 forms a complex with Rac and IRSp53 and then binds 
G-actin and Arp2/3, thus inducing actin polymerization and 
lamellipodium formation.65 On the other hand, Cestra et al.66 
SH2 domain of the p85 subunit of PI 3-kinase, thus recruiting 
PI 3-kinase to the membrane.55,56 In addition to this role, Cbl is 
an E3 ubiquitin ligase that fulfills its roles by ubiquitinating its 
binding partners. Here, I summarize its roles in regulating cell 
adhesion and migration (Fig. 2).
Cbl negatively regulates cell adhesions. The involvement of 
Cbl in negatively regulating cell adhesions has been demonstrated 
in several publications. Cbl inhibits cell adhesion by ubiquitinat-
ing α5 integrin in osteoblasts,57 and suppresses T cell adhesion by 
ubiquitinating FAK or inhibiting Rap1 activation.58 By contrast, 
the macrophages from Cbl-b (-/-) mice exhibit increased recruit-
ment in thioglycollate-induced peritonitis and mononuclear 
phagocytes derived from Cbl-b (-/-) bone marrow show increased 
adhesion to endothelial cells.59
C-Cbl and α5 integrin. Alpha5 integrin co-immunoprecipi-
tates with c-Cbl and it also co-localizes with c-Cbl at the lead-
ing edge of membrane ruffles, indicating that α5 integrin is a 
c-Cbl-binding protein. Binding of c-Cbl to α5 integrin results in 
its ubiquitination and degradation.57 In human calvarial osteo-
blasts expressing activated FGFR2, FGF stimulation causes α5 
integrin ubiquitination and degradation and reduces the adhe-
sions of osteoblasts on fibronectin. However, expressing a c-Cbl 
mutant lacking the RING finger domain or a c-Cbl mutant with 
mutation in the PTB domain restores α5 integrin levels. Also, 
lactacystin, a potent proteasome inhibitor, restores α5 integrin 
levels in FGF-stimulated osteoblasts. In addition, exogenous 
expression of α5 integrin rescues cell attachment. Thus, c-Cbl-
mediated ubiquitination and degradation of α5 integrin reduce 
the adhesion of the osteoblasts to fibronectin.57
Cbl and Rap1. Rap1 mediates integrin activation through 
RIAM,60,61 while the activity of Rap1 is stimulated by C3G, a 
guanine nucleotide exchange factor that is activated by CrkL 
interaction.62 Shao et al.58 reported that Cbl promotes CrkL 
ubiquitination, which in turn inhibited the interaction of CrkL 
with C3G, thus suppressing Rap1 activation; Cbl deficiency 
caused an increase in the activity of C3G, Rap1 activation, and 
integrin-mediated cell adhesion in Cbl (-/-) thymocytes. Cbl-b 
Figure 2. Cbl regulates cell adhesion and migration. Cbl targets α5 integrin, CrkL and FAK for ubiquitination thus suppressing integrin activation and 
cell adhesion. it also negatively regulates actin polymerization by ubiquitinating mDab1 and wave2 and downregulates growth factor receptors, such 
as eGFr, PDGFr, Met and Kit, by ubiquitinating the receptors to induce cell polarization.
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are regulators of cell migration, currently there are no direct links 
between the ubiquitination of these PTKs and cell migration.
Smurfs
Smurf (Smad ubiquitin regulatory factor) 1 and 2 are members 
of the Nedd4 family ubiquitin ligases. These enzymes feature 
an amino terminal C2 domain and 2–3 WW domains that are 
responsible for cellular localization and substrate recognition, and 
a catalytic carboxyl terminal HECT domain (Fig. 3).80 Smurf1 is 
localized in both the nucleus and the cytoplasm. A nuclear export 
signal sequence in the carboxyl terminus of Smurf1 is responsible 
for its cytoplasmic distribution.81 Smurf2 is predominantly a 
nuclear protein, but it can form a complex with Smad7, resulting 
in its export and recruitment to the activated TGF receptor.82
Smurfs were originally identified as regulators of TGFβ fam-
ily signaling,83,84 but recent studies show that they regulate a wide 
range of signaling networks including the Wnt signaling pathway.85 
TGFβ family signaling regulates a wide range of biological pro-
cesses including cell growth, differentiation and development.80,86,87 
Signaling is initiated with the activation of Type I and II serine/
threonine receptor kinases through dimerization of TGFβ recep-
tors, which phosphorylate the receptor-regulated Smads (R-Smads) 
1, 2, 3, 5 and 8. The phosphorylated Smads then interact with the 
common Smad, Smad4, resulting in translocation to the nucleus 
and transcription initiation.88 Smurf1 negatively regulates bone 
morphogenetic protein signaling by ubiquitinating R-Smad 1 and 
5.89,90 Smurf1 also regulates transcription by ubiquitinating Runx2, 
a bone-specific transcription factor.91 On the other hand, Smurf2 
inhibits TGFβ signaling mainly through binding and ubiquitinat-
ing R-Smad 2 and TGFβ receptor.92,93
Besides the canonical roles in cell growth and differentiation, 
accumulating evidence indicates that Smurfs play key roles in 
regulating cell adhesion and migration (Fig. 4). First, Smurf1 is 
localized to lamellipodia and filopodia and a fraction of Smurf1 is 
also localized to focal adhesions.94,95 Second, Smurfs ubiquitinate 
a number of molecules that regulate cell adhesion and migra-
tion, such as RhoA, Rap1, talin head and hPEM-2.94-97 Third, 
exogenous expression of Smurf1 promotes protrusive activity;94 
overexpression of Smurf2 promotes the migration of a human tro-
phoblast cell line.93 Fourth, inhibition of Smurf1 by Smurf1C699A, 
a ligase-dead mutant or siRNA abrogates protrusive activity and 
cell migration;94 also, inhibition of Smurf2 by Smurf2C716G, a 
ligase-dead mutant or siRNA induces cell rounding and inhibits 
cell migration and metastasis in cancer cell lines.98 These results 
collectively implicate Smurfs in the regulation of cell adhesion 
and migration.
Smurf1 and RhoA. The discovery of Smurf1-mediated RhoA 
ubiquitination represents the first direct evidence for the role of 
Smurf in cell migration.94 RhoA plays a pivotal role in cell migra-
tion by regulating stress fiber and focal adhesion formation.99 
In migratory cells, RhoA activity is low at the leading edge and 
higher at the rear and sides.100 Wang et al.94 reported that Smurf1 
is localized to lamellipodia and targets RhoA there for ubiquit-
ination and degradation, thus inhibiting stress fiber formation 
and facilitating protrusive activity and cell migration.94 However, 
demonstrated that WAVE2 is a substrate for Cbl and is ubiquit-
inated by Cbl when it is phosphorylated by Abl. Thus, ubiquitina-
tion of WAVE2 by Cbl may provide a mechanism for negatively 
regulating actin polymerization and lamellipodium dynamics 
during cell migration.
Cbl regulates cell migration by downregulating growth 
factor receptors. Growth factors induce directional migration 
by promoting cell polarization, which requires cells to regulate 
their growth factor receptors temporally and spatially. Studies by 
Jékely et al.67 showed that Cbl modulates the spatial distribution 
of growth factor receptors in cells through ubiquitinating the 
receptors, thus promoting cell polarization; cells deficient in Cbl 
had severe migration defects,67 indicating that Cbl is required for 
cell migration.
Cbl and EGFR. EGFR is a substrate for Cbl.49,68-70 SHIP2, an 
enzyme that dephosphorylates phosphatidylinositol 3,4,5-tris-
phosphate, interacts with Cbl and has an inhibitory effect on 
Cbl.71 SHIP2 knockdown in HeLa cells promotes Cbl-mediated 
EGFR ubiquitination and degradation.71 SHIP2 knockdown also 
inhibits cell adhesions and spreading, but it is unknown whether 
this inhibition is caused by Cbl.
Cbl and PDGFR. PDGFR is also a substrate for Cbl. 
Overexpression of Cbl promotes PDGF-induced ubiquitina-
tion and degradation of the PDGFR, whereas a point mutation 
(G306E) that inactivates the tyrosine kinase binding domain of 
Cbl abolishes Cbl’s ability to induce ubiquitination and degrada-
tion of the PDGFR.72,73 These results indicate that Cbl negatively 
regulates PDGF signaling.
Cbl and Met. Met, a receptor tyrosine kinase, is the receptor 
for hepatocyte growth factor/scatter factor (HGF). HGF induces 
c-Cbl-mediated ubiquitination of Met, while a Met mutant 
that is not ubiquitinated by Cbl promotes its oncogenic activa-
tion,48,74,75 indicating that c-Cbl is a negative regulator of HGF/
Met signaling.
Cbl and Kit. Kit is a receptor tyrosine kinase and the receptor 
for stem cell factor (SCF). SCF stimulates Kit-mediated phospho-
rylation of Cbl, which in turn causes ubiquitination and degrada-
tion of KIT, leading to downregulation of KIT signaling.47,76
Cbl downregulates non-receptor protein tyrosine kinases 
(PTKs). Cbl ubiquitinates a great number of non-receptor 
PTKs,35,77-79 including Syk, Fyn, Src and Abl. Although these PTKs 
Figure 3. Domain structures of Smurf1 and Smurf2. Smurf1 has an 
amino terminal C2 domain, two ww domains and a catalytic carboxyl 
terminal HeCT domain. A nuclear export signal (NeS) sequence (i606G-
GLDKiDL614) localizes in the carboxyl terminus of Smurf1. Smurf2 has an 
amino terminal C2 domain, three ww domains and a catalytic carboxyl 
terminal HeCT domain.
14 Cell Adhesion & Migration volume 4 issue 1
MDA-MB-231 cells,98 and indicates that further investigation is 
required to clarify the role of Smurf2 in cell migration.
Smurf2 and TGFβ type I receptor. Trophoblast cell migration 
and invasion are key steps during embryo implantation. These 
are regulated by Smurf2-mediated degradation of TGFβ type I 
receptor (TGFβR I).93 Overexpression of Smurf2 in a human tro-
phoblast cell line leads to TGFβR I degradation, and enhances 
cell migration and invasion. In contrast, Smurf2 knockdown 
using siRNA causes a significant increase in TGFβR I levels and 
inhibits the migration of trophoblast cells.
Smurf2 and Rap1B. Rap1 is a small GTPase that regulates 
integrin activation, cell migration, cell polarity and differentia-
tion.108,109 Rap1B is a substrate for Smurf2. Smurf2 ubiquitinates 
inactive Rap1B and mediates its degradation in proteasomes.96 
Smurf2-mediated degradation of Rap1B is essential for neuronal 
polarity. Because of the role of Rap1 in cell migration, Smurf2-
mediated Rap1B ubiquitination may regulate cell migration.
HDM2
HDM2 is the human counterpart of Mdm2 (murine double 
minute 2), which encodes a 90-kDa protein. Hdm2 is over-
expressed in a wide range of human cancers, including breast 
cancers, esophageal cancers, lung cancers, and malignant 
melanomas.110 HDM2 is a RING finger ubiquitin ligase that 
mediates the ubiquitination of p53, a classic tumor suppres-
sor.111-113 It has been reported that HDM2 also targets NFAT 
(nuclear factor of activated T cells) for ubiquitination and 
degradation.114 NFAT is a transcription factor that is emerg-
ing as a novel positive regulator of cell migration and cancer 
invasion.114-116 It is downstream of the PI 3-kinase-Akt-HDM2 
pathway.114 Stimulation of the PI 3-kinase pathway results in 
sequential activation of Akt and then HDM2, which in turn 
mediates NFAT ubiquitination and degradation, thus inhibit-
ing the migration of cancer cells.114
excess Smurf-mediated RhoA degradation impairs cell migra-
tion. For example, gene silencing of synaptopodin, an actin-
associated protein that competitively inhibits Smurf1-mediated 
ubiquitination of RhoA, induces the loss of stress fibers and non- 
polarized filopodium formation and inhibits cell migration.101 
Thus, Smurf1-mediated ubiquitination of RhoA is responsible 
for precise temporal and spatial regulation of RhoA, which is 
required for optimal cell migration.
Smurf1 and talin head domain. Talin is an actin and 
β-integrin tail-binding protein that regulates integrin activation 
and focal adhesion turnover.102-104 Talin is cleaved into a ~47-kDa 
head domain and a ~190-kDa rod domain by calpain.105 The 
talin head (TH) domain localizes to focal adhesions and stimu-
lates integrin activation.105,106 Smurf1 binds to TH and mediates 
TH ubiquitination and degradation, thus leading to focal adhe-
sion disassembly.95 This action of Smurf1 is inhibited by Cdk5, 
a regulator of cell migration and cancer metastasis. Cdk5 phos-
phorylates TH at Ser425 and abrogates its binding to Smurf1, thus 
inhibiting TH ubiquitination and focal adhesion disassembly.95 
Thus, precise coordination of the roles of Smurf1 and Cdk5 is 
required for optimal cell migration.
Smurf1 and hEMP-2. hPEM-2, a guanine nucleotide exchange 
factor for Cdc42, is also a substrate of Smurf1.97 Smurf1 binds the 
PH domain of hPEM-2 via its C2 domain and induces hPEM-2 
ubiquitination and degradation in cells. Thus, Smurf1-mediated 
ubiquitination of hPEM-2 may play a role in the spatiotemporal 
regulation of Cdc42 during cell migration.
Smurf2 and Smurf1. Fukunaga et al.107 reported that Smurf2 
binds Smurf1 and induces its ubiquitination and degradation, 
but Smurf1 fails to induce degradation of Smurf2. They also 
showed that knockdown of Smurf2 in human breast cancer 
MDA-MB-231 cells causes an increase in the Smurf1 protein 
level, and promotes cell migration in vitro and bone metastasis 
in vivo. However, this result is inconsistent with studies showing 
that Smurf2 knockdown inhibits the migration and metastasis of 
Figure 4. Smurfs regulate cell adhesion and migration. Smurf1 ubiquitinates rhoA and hPeM-2, thus inhibiting actin polymerization and regulating 
cell protrusions. it also regulates focal adhesion dynamics and cell migration through targeting talin head domain for ubiquitination and degrada-
tion. Smurf2 mediates rap1B ubiquitination and is implicated in integrin suppression, and promotes cell polarization and migration by ubiquitinating 
TGFβr. in addition, it may ubiquitinate Smurf1.
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of paxillin at focal adhesions and promotes mesodermal cell 
migration during gastrulation.127
RNF5, a RING finger domain ubiquitin ligase, was origi-
nally identified as a regulator of growth and development of 
Caenorhabditis elegans.130 The human homologue of RNF5 inter-
acts with the NH
2
-terminus of paxillin and mediates its ubiquit-
ination.131 RNF5 requires intact RING and C-terminal domains 
to mediate paxillin ubiquitination. However, instead of inducing 
paxillin degradation, RNF5-mediated ubiquitination causes a 
translocation of paxillin from focal adhesions to the cytoplasm. 
Overexpression of RNF5 inhibits cell migration in wound heal-
ing assays.131
Conclusions and Future Prospects
E3 ubiquitin ligases are emerging as important regulators of 
cell adhesion and migration. They regulate cell adhesion and 
migration through ubiquitinating specific substrates, such as 
adhesion molecules, actin polymerization regulators, small 
GTPases, protein kinases, growth factor receptors and tran-
scription factors. These ubiquitin ligases may temporally and 
spatially regulate their substrates, thus promoting cell polariza-
tion, such as Smurf1-mediated ubiquitination of RhoA. They 
may also regulate the levels of cell migration promoters, thus 
modulating the migration of cells, such as SCFβ-TRCP-mediated 
Snail ubiquitination. These ligases also target many molecules 
that regulate cell adhesion and migration for ubiquitination and 
degradation, but direct links between the ubiquitination of these 
molecules and cell migration remain to be elucidated. Future 
studies will focus on the roles and the underlying mechanisms 
of different E3 ubiquitin ligases in cell adhesion and migration. 
It is of great importance to identify other E3 ubiquitin ligases 
and novel substrates that regulate cell adhesion and migration. 
How ubiquitin ligases temporally and spatially regulate their 
substrates and whether this kind of regulation participates in 
cycling processes such as focal adhesion assembly/disassembly 
during cell migration is another key issue. Eventually, we would 
like to understand how E3 ubiquitin ligases coordinate other 
signaling pathways that may regulate both inhibition and accel-
eration of cell migration.
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BCA2
The BCA2 protein is a RING finger E3 ubiquitin ligase and is 
overexpressed in human breast tumors. Wild-type BCA2 signifi-
cantly promotes the migration of MCF-7 cells in wound healing 
assays, whereas mutants that are deficient in autoubiquitination 
(RING mutation or NH
2
-terminal lysine mutations) signifi-
cantly inhibit migration.117
SCFβ-TRCP
SCFβ-TRCP is a ubiquitin ligase complex that consists of Skp1, Cul1 
and the F-box protein β-TRCP and it is responsible for mediating 
phosphorylation dependent ubiquitination of a number of protein 
substrates, including IκBα, WEE1, catenin and Snail.118 Snail is a 
key transcription repressor of E-cadherin and is essential for epithe-
lial-mesenchymal transition (EMT), which is critical for epithelial 
cell migration and cancer metastasis.119,120 Snail is phosphorylated 
by GSK-3 and subsequently is targeted for ubiquitination and deg-
radation by SCFβ-TRCP, whereas that the small C-terminal domain 
phosphatase (SCP), a specific phosphatase for Snail, induces Snail 
dephosphorylation and inhibits Snail ubiquitination and degrada-
tion, thus suppressing E-cadherin expression and promoting cell 
migration.121,122 The NFκB pathway also abrogates Snail ubiquit-
ination and degradation through COP9 signalosome 2-mediated 
inhibition of SCFβ-TRCP, thus promoting cell migration.123
TRIM32
Tripartite motif protein 32 (TRIM32) is a RING domain E3 
ubiquitin ligase that is highly expressed in human head and neck 
squamous cell carcinoma.124 It features a RING and a B-box fin-
ger domain, a coiled-coil domain at the N-terminus and mul-
tiple NHL domains at the C-terminus.125 TRIM32 binds to and 
ubiquitinates Abl interactor 2 (Abi2), a tumor suppressor and a 
cell migration inhibitor.126 Overexpression of TRIM32 causes 
Abi2 degradation and enhances cell growth and cell migration, 
whereas a dominant-negative mutant of TRIM32 without the 
RING domain inhibits Abi2 degradation.
XRNF185 and RNF5
XRNF185 is a Xenopus RING finger domain ubiquitin ligase. 
It shares 91% homology with human RNF185. XRNF185 binds 
and ubiquitinates paxillin,127 a signaling adaptor and a focal 
adhesion-associated protein implicated in regulating focal adhe-
sion dynamics and cell migration.128,129 It enhances the turnover 
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